PI Industries secures registration for indigenous insecticide Pioxaniliprole

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • PI Industries secured registration for Pioxaniliprole, India's first indigenous insecticide
  • Approval granted under Insecticides Act, 1968 for TIM and FIM categories
  • Product branded as 'Pioxazon' targets the domestic market exclusively
  • Development reflects decade-long research effort by the company
powered bylight_fuzz_icon
51542021

*this image is generated using AI for illustrative purposes only.

PI Industries Limited has secured registration for Pioxaniliprole, India’s first indigenously discovered insecticide, under section 9(3) of the Insecticides Act, 1968. The approval, granted by the Ministry of Agriculture & Farmers Welfare, covers the Technical Intermediate Material (TIM) and Formulated Intermediate Material (FIM) categories.

The registration committee approved the molecule on September 10, 2026, with the decision published on September 21, 2026. The company disclosed the development pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Product Details

Pioxaniliprole, branded as 'Pioxazon', represents a decade of research by the company. It is currently approved for the domestic market only. The company plans to launch the product in India soon to address crop productivity challenges.

Particulars Details
Product Name Pioxaniliprole (Branded as 'Pioxazon')
Registration Date September 21, 2026
Category Insecticide
Market Focus Domestic

Strategic Significance

The approval underscores PI Industries' evolution into a global-scale innovator in Agri Sciences. As an indigenously developed molecule, Pioxaniliprole reduces dependency on imported active ingredients and supports the country's agricultural innovation journey.

Historical Stock Returns for PI Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-1.90%+2.78%-7.68%-20.69%-37.35%0.0%

When does PI Industries plan to initiate the registration process for Pioxaniliprole in key international markets beyond India?

How is the launch of Pioxazon expected to impact PI Industries' revenue mix and gross margins compared to its existing generic product portfolio?

What specific pest resistance challenges in Indian agriculture is Pioxaniliprole designed to overcome, and how does this differentiate it from current market offerings?

PI Industries to meet UTI Mutual Fund, analysts on September 23

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • PI Industries to hold meeting with UTI Mutual Fund and analysts on September 23, 2026
  • Interaction scheduled in Mumbai under SEBI LODR Regulation 30(6)
  • Company confirms no unpublished price-sensitive information will be shared
powered bylight_fuzz_icon
51276461

*this image is generated using AI for illustrative purposes only.

PI Industries will host a one-on-one interaction with UTI Mutual Fund and other analysts and investors on September 23, 2026. The meeting is scheduled to take place in Mumbai.

The company issued the intimation pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory requirement mandates disclosure of interactions with analysts and institutional investors.

Meeting Details

Date Participant Venue Type
September 23, 2026 UTI Mutual Fund Mumbai One-on-One

Shruti Joshi, Company Secretary and Compliance Officer, confirmed that no unpublished price-sensitive information will be shared during the session. The details are subject to change based on exigencies from either the investor or the company.

This disclosure serves as an informational record for stakeholders and exchanges.

Historical Stock Returns for PI Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-1.90%+2.78%-7.68%-20.69%-37.35%0.0%
Disclaimer: This article is AI-generated using data from LiveSquawk. ScanX is not liable for any inaccuracies.

What specific strategic initiatives or financial guidance is PI Industries likely to highlight to UTI Mutual Fund given the current agrochemical market trends?

How might the outcome of this one-on-one interaction influence UTI Mutual Fund's portfolio allocation for PI Industries in the upcoming quarter?

Are there any pending regulatory approvals or new product launches that PI Industries may address to alleviate investor concerns during this meeting?

More News on PI Industries

1 Year Returns:-37.35%